MediWound (MDWD) Enterprise Value (2013 - 2025)
MediWound's (MDWD) quarterly Enterprise Value came in at -$4.8 million in Q4 2025, up 92.94% year-on-year from -$2.5 million in Q4 2024, and up 91.88% quarter-over-quarter from -$59.1 million in Q3 2025.
MediWound (MDWD) Enterprise Value (2013 - 2025) Analysis & Trends
MediWound's Enterprise Value history runs 13 years deep, the most recent figure standing at -$4.8 million for Q4 2025.
- On a quarterly basis, Enterprise Value rose 92.94% year-over-year to -$4.8 million in Q4 2025; TTM through Dec 2025 was -$4.8 million, a 92.94% increase from a year earlier, with the FY2025 full-year figure at -$4.8 million, up 92.94% from the prior year.
- Enterprise Value rose to -$4.8 million in Q4 2025 per MDWD's latest filing, from -$59.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$4.8 million in Q4 2025 and bottomed at -$83.0 million in Q2 2023.
- The 5-year median for Enterprise Value is -$36.4 million (2024), against an average of -$35.0 million.
- Across the five-year window, Enterprise Value tumbled 393.35% in 2023 and soared 92.94% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$11.0 million in 2021, then tumbled by 206.85% to -$33.9 million in 2022, then dropped by 23.05% to -$41.7 million in 2023, then sank by 63.07% to -$68.0 million in 2024, then surged by 92.94% to -$4.8 million in 2025.
- Per Business Quant, the three latest MDWD Enterprise Value figures stand at -$4.8 million (Q4 2025), -$59.1 million (Q3 2025), and -$40.5 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | MediWound | 183.16 Mn | 178.36 Mn | 278,000.00 | -4.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.80 Mn |
| Sep 30, 2025 | -59.09 Mn |
| Jun 30, 2025 | -40.53 Mn |
| Mar 31, 2025 | -38.27 Mn |
| Dec 31, 2024 | -68.01 Mn |
| Sep 30, 2024 | -45.56 Mn |
| Jun 30, 2024 | -37.29 Mn |
| Mar 31, 2024 | -35.57 Mn |
| Dec 31, 2023 | -41.71 Mn |
| Sep 30, 2023 | -45.52 Mn |
| Jun 30, 2023 | -82.98 Mn |
| Mar 31, 2023 | -57.20 Mn |
| Dec 31, 2022 | -33.90 Mn |
| Sep 30, 2022 | -15.07 Mn |
| Jun 30, 2022 | -16.82 Mn |
| Mar 31, 2022 | -16.84 Mn |
| Dec 31, 2021 | -11.05 Mn |
| Sep 30, 2021 | -13.87 Mn |
| Jun 30, 2021 | -17.87 Mn |
| Mar 31, 2021 | -17.86 Mn |